Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SCRiCaViPS Screening and Rehabilitation of Visual Field Defects in Post-Stroke Patients

NCT07317739 is registered in ClinicalTrials.gov with Fondazione David Chiossone - Impresa Sociale as lead sponsor.

NCT NCT07317739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07317739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SCRiCaViPS Screening and Rehabilitation of Visual Field Defects in Post-Stroke Patients
Lead sponsor
Fondazione David Chiossone - Impresa Sociale
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
March 31, 2027
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemianopia, visual field defect following cerebrovascular accident